Tecogen's Product Sales Soar, But Cash Drains Amidst Continued Losses

TL;DR

**TGEN's product sales are booming, but they're still bleeding cash, making the recent $18M capital raise a critical lifeline, not a victory lap.**

AI Summary

TECOGEN INC. (TGEN) reported a significant increase in total revenues for the three months ended June 30, 2025, reaching $7,294,820, up from $4,727,787 in the prior year, primarily driven by a surge in product sales to $3,155,323 from $119,673. Despite this revenue growth, the company posted a consolidated net loss of $1,473,155 for the quarter, a slight improvement from the $1,510,476 loss in Q2 2024. For the six months ended June 30, 2025, total revenues increased to $14,572,590 from $10,913,883, with product sales jumping to $5,689,132 from $1,611,071. The net loss for the six-month period improved to $2,133,644 from $2,598,092 in the same period last year. Cash and cash equivalents significantly decreased to $1,640,864 as of June 30, 2025, from $5,405,233 at December 31, 2024, largely due to net cash used in operating activities totaling $3,775,620. A notable strategic move post-quarter was the closing of a public offering on July 21, 2025, raising approximately $18,160,750 in net proceeds from the sale of 3,985,000 shares of common stock at $5.00 per share.

Why It Matters

For investors, TGEN's substantial product revenue growth, up over 2500% year-over-year for the quarter, signals strong market demand for its CHP systems, potentially indicating a competitive edge in the energy efficiency sector. However, the persistent net losses and significant cash burn, with cash and cash equivalents dropping by over 69% since December 2024, raise concerns about profitability and liquidity. The recent $18.16 million public offering provides a crucial capital injection, but investors will be watching closely to see if this funding can translate into sustained profitability and positive cash flow, especially given the competitive landscape in the combined heat and power market.

Risk Assessment

Risk Level: high — The company reported a consolidated net loss of $1,473,155 for the three months ended June 30, 2025, and a net loss of $2,133,644 for the six months ended June 30, 2025. Cash and cash equivalents decreased significantly from $5,405,233 at December 31, 2024, to $1,640,864 at June 30, 2025, representing a 69.6% decline, primarily due to $3,775,620 in net cash used in operating activities, indicating ongoing operational cash burn.

Analyst Insight

Investors should monitor how TECOGEN INC. utilizes the $18,160,750 net proceeds from its recent public offering to address its significant cash burn and achieve profitability. While product revenue growth is strong, the persistent net losses and negative operating cash flow necessitate a clear path to sustainable positive earnings and cash generation before considering a long-term position.

Financial Highlights

debt To Equity

2.17

revenue

$7,294,820

operating Margin

-38.7%

total Assets

$28,351,837

total Debt

$19,410,386

net Income

-$1,473,155

eps

N/A

gross Margin

33.8%

cash Position

$1,640,864

revenue Growth

+54.3%

Revenue Breakdown

Key Numbers

• $7,294,820 — Total Revenues (For the three months ended June 30, 2025, up from $4,727,787 in Q2 2024)
• $3,155,323 — Product Revenues (For the three months ended June 30, 2025, a significant increase from $119,673 in Q2 2024)
• $1,473,155 — Consolidated Net Loss (For the three months ended June 30, 2025, an improvement from $1,510,476 in Q2 2024)
• $14,572,590 — Total Revenues (For the six months ended June 30, 2025, up from $10,913,883 in H1 2024)
• $2,133,644 — Consolidated Net Loss (For the six months ended June 30, 2025, an improvement from $2,598,092 in H1 2024)
• $1,640,864 — Cash and Cash Equivalents (As of June 30, 2025, a decrease from $5,405,233 at December 31, 2024)
• $3,775,620 — Net Cash Used in Operating Activities (For the six months ended June 30, 2025, indicating significant cash burn)
• $18,160,750 — Net Proceeds from Public Offering (Received on July 21, 2025, after the reporting period)
• 29,690,798 — Shares of Common Stock Outstanding (As of August 12, 2025)

Key Players & Entities

• TECOGEN INC. (company) — Registrant and primary entity in the filing
• Roth Capital Partners, LLC (company) — Sole underwriter and manager for the public offering
• American DG Energy Inc. (company) — Wholly-owned subsidiary of Tecogen Inc.
• American DG New York, LLC (company) — Joint venture in which American DG Energy Inc. holds a 51.0% interest
• NYSE American LLC (regulator) — Stock exchange where Tecogen Inc. common stock is listed

FAQ

Risk Factors

• Cash Burn and Liquidity Concerns [high — financial]: The company experienced a significant decrease in cash and cash equivalents from $5,405,233 at December 31, 2024, to $1,640,864 as of June 30, 2025. This was primarily driven by net cash used in operating activities totaling $3,775,620 for the six months ended June 30, 2025. While a public offering post-quarter raised approximately $18.16 million, the substantial operating cash burn remains a concern.
• Dependence on Product Sales Growth [medium — operational]: The dramatic increase in product sales revenue to $3,155,323 in Q2 2025 from $119,673 in Q2 2024 highlights a significant shift. The company's performance is now heavily reliant on the sustained success and volume of these product sales, which could be subject to market demand fluctuations and supply chain issues.
• Persistent Net Losses [medium — financial]: Despite revenue growth, TGEN continues to report net losses. The consolidated net loss for Q2 2025 was $1,473,155, a slight improvement from $1,510,476 in Q2 2024. For the first six months, the net loss was $2,133,644, down from $2,598,092. This indicates ongoing challenges in achieving profitability.
• Competition in Energy Solutions [medium — market]: The energy solutions market is competitive, with various players offering alternative technologies and services. TGEN's ability to maintain market share and grow revenue depends on its technological innovation, cost-effectiveness, and customer adoption rates.
• Leverage from Finance Leases [low — financial]: Finance lease obligations have increased significantly, from $325,235 at December 31, 2024, to $675,198 as of June 30, 2025 (net of current portion). This increased financial leverage could add pressure to future cash flows.
• Inventory Management [low — operational]: Inventories remain relatively stable at $9,679,229 as of June 30, 2025, compared to $9,634,005 at December 31, 2024. Effective management of these inventory levels is crucial to support the increased product sales without incurring excessive carrying costs or obsolescence.

Industry Context

Tecogen operates in the distributed generation and combined heat and power (CHP) market, providing clean and efficient energy solutions. The industry is influenced by factors such as energy prices, environmental regulations, and the demand for reliable, on-site power. Competitors range from large industrial conglomerates to specialized technology providers, all vying for market share in a sector increasingly focused on sustainability and energy independence.

Regulatory Implications

As a publicly traded company, TGEN is subject to SEC regulations and reporting requirements. Changes in environmental regulations or energy policies could impact the demand for its products and services. Compliance with manufacturing standards and safety regulations for its energy generation equipment is also critical.

What Investors Should Do

1. Monitor the sustainability of product sales growth.
2. Analyze the impact of the recent public offering on cash flow and debt levels.
3. Evaluate the company's path to profitability.
4. Assess the operational efficiency and cost of goods sold for product sales.

Key Dates

• 2025-06-30: End of Q2 2025 Reporting Period — Marks the period for which the financial results in this 10-Q are reported, showing significant revenue growth but continued net losses.
• 2025-07-21: Closing of Public Offering — Post-period event that raised approximately $18.16 million, significantly bolstering the company's cash position and addressing liquidity concerns.
• 2025-08-12: Date of Common Stock Outstanding Disclosure — Provides the latest share count (29,690,798) for per-share calculations and market capitalization analysis.

Glossary

Accumulated deficit

The cumulative net losses of a company since its inception that have not been offset by net profits. (Indicates the company has historically incurred more expenses than revenues, standing at a deficit of $49,763,921 as of June 30, 2025.)

Right-of-use assets

Assets recognized under lease accounting standards representing the lessee's right to use an underlying asset for the lease term. (These assets, related to both operating and finance leases, represent a significant portion of the company's long-term assets.)

Unfavorable contract liability

A liability recognized when the costs of fulfilling a contract exceed the expected revenue from that contract. (The company has liabilities related to unfavorable contracts, both current and long-term, which impact its financial obligations.)

Non-controlling interest

The portion of equity in a subsidiary that is not attributable to the parent company. (Represents a small minority ownership stake in a consolidated subsidiary, impacting the total equity attributable to Tecogen Inc. stockholders.)

Additional paid-in capital

The amount investors have paid for stock above its par or stated value. (Shows significant capital raised from equity issuance, totaling $58,837,181 as of June 30, 2025.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, TGEN has demonstrated substantial revenue growth, particularly in product sales, which surged by over 2500% in Q2 2025. However, this top-line improvement has not yet translated into profitability, as the company continues to report net losses, albeit slightly reduced. Operating expenses, especially general and administrative costs, have increased, contributing to the ongoing net loss. The company's cash position has significantly declined, necessitating a substantial capital raise post-period.

Key Financial Figures

• $0.001 — ange on Which Registered Common Stock, $0.001 par value per share TGEN NYSE American

Filing Documents

• tgen-20250630.htm (10-Q) — 1329KB
• tgn-20250630xex311.htm (EX-31.1) — 9KB
• tgn-20250630xex312.htm (EX-31.2) — 9KB
• tgn-20250630xex321.htm (EX-32.1) — 4KB
• tgn-20250630xex322.htm (EX-32.2) — 4KB
• tgen-20250630_g1.jpg (GRAPHIC) — 5KB
• 0001537435-25-000131.txt ( ) — 8352KB
• tgen-20250630.xsd (EX-101.SCH) — 69KB
• tgen-20250630_cal.xml (EX-101.CAL) — 108KB
• tgen-20250630_def.xml (EX-101.DEF) — 341KB
• tgen-20250630_lab.xml (EX-101.LAB) — 778KB
• tgen-20250630_pre.xml (EX-101.PRE) — 540KB
• tgen-20250630_htm.xml (XML) — 1271KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements Condensed Consolidated Balance Sheets (Unaudited) June 30, 2025 and December 31, 2024 1 Condensed Consolidated Statements of Operations (Unaudited) Three Months Ended June 30, 2025 and 2024 2 Condensed Consolidated Statements of Operations (Unaudited) Six Months Ended June 30, 2025 and 2024 3 Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Three and Six Months Ended June 30, 2025 and 2024 4 Condensed Consolidated Statements of Cash Flows (Unaudited) Three and Six Months Ended June 30, 2025 and 2024 5 Notes to Unaudited Condensed Consolidated Financial Statements 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 36 Item 4.

Controls and Procedures

Controls and Procedures 37

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 37 Item 1A.

Risk Factors

Risk Factors 38 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 38 Item 3. Defaults in Senior Securities 38 Item 4. Mine Safety Disclosures 38 Item 5. Other Information 39 Item 6. Exhibits 40

Signatures

Signatures Signature Page 41 References in this Form 10-Q to "we", "us", "our"', the "Company" and "Tecogen" refers to Tecogen Inc. and its consolidated subsidiaries, unless otherwise noted. TECOGEN INC.

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

- Financial Statements

Item 1 - Financial Statements CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) June 30, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 1,640,864 $ 5,405,233 Accounts receivable, net 6,640,483 6,026,545 Inventories, net 9,679,229 9,634,005 Unbilled revenue 126,738 398,898 Prepaid and other current assets 949,256 680,565 Total current assets 19,036,570 22,145,246 Long-term assets: Property, plant and equipment, net 1,820,059 1,738,036 Right-of-use assets - operating leases 1,728,780 1,730,358 Right-of-use assets - finance leases 933,671 452,390 Intangible assets, net 2,330,959 2,513,189 Goodwill 2,346,566 2,346,566 Other assets 155,232 166,474 TOTAL ASSETS $ 28,351,837 $ 31,092,259 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Related party notes, current portion $ — $ 1,548,872 Accounts payable 4,946,218 4,142,678 Accrued expenses 2,976,211 2,890,886 Deferred revenue, current portion 4,420,644 6,701,131 Operating lease obligations, current portion 481,891 430,382 Finance lease obligations, current portion 173,362 85,646 Acquisition liabilities, current portion 883,541 902,552 Unfavorable contract liability, current portion 83,962 113,449 Total current liabilities 13,965,829 16,815,596 Long-term liabilities: Related party notes, net of current portion 1,067,848 — Deferred revenue, net of current portion 1,252,831 1,165,951 Operating lease obligations, net of current portion 1,295,450 1,341,789 Finance lease obligations, net of current portion 675,198 325,235 Acquisition liabilities, net of current portion 878,151 1,008,760 Unfavorable contract liability, net of current portion 275,079 309,390 Total liabilities 19,410,386 20,966,721 Commitments and contingencies Stockholders' equity: Tecogen Inc. stockholders' equity: Common stock, $ 0.001 par value; 100,000,000 shares authorized; 25,571,490 issued and outstanding at June 30, 2025 and 24,950,261 shares issued and outstanding a

View Full Filing

View this 10-Q filing on SEC EDGAR